Literature DB >> 9395803

Preoperative versus postoperative pethidine for extraction of impacted third molars.

S T Chew1, T C Low.   

Abstract

We have studied the pre-emptive analgesic effects of pethidine by comparing its analgesic effects given before or immediately after operation in a randomized, double-blind study of 40 patients undergoing removal of bilateral impacted third molars under general anaesthesia. Group 1 patients received pethidine 50 mg as a 1 ml injection 1 to 2 hours before operation and normal saline 1 ml intramuscularly immediately after surgery. Group 2 patients received normal saline 1 ml intramuscularly before operation and pethidine 50 mg as a 1 ml injection immediately after surgery. Outcome measures included perception of pain on a visual analogue scale (VAS), the number of patients who required postoperative pethidine, time to first postoperative pethidine injection and total dose of pethidine given. Four patients in group 1 compared to 8 in group 2 required postoperative pethidine but this was not statistically significant. The VAS scores, time to first postoperative pethidine injection and total dose of pethidine also did not differ significantly between the 2 groups. We concluded that preoperative administration of pethidine intramuscularly did not confer additional analgesic effects compared with a similar dose given after surgery.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9395803

Source DB:  PubMed          Journal:  Ann Acad Med Singapore        ISSN: 0304-4602            Impact factor:   2.473


  2 in total

1.  Pre-emptive and preventive opioids for postoperative pain in adults undergoing all types of surgery.

Authors:  Brett Doleman; Jo Leonardi-Bee; Thomas P Heinink; Debamita Bhattacharjee; Jon N Lund; John P Williams
Journal:  Cochrane Database Syst Rev       Date:  2018-12-03

2.  Radiographic study of dental anomalies in Brazilian patients with neuropsychomotor disorders.

Authors:  Erick Nelo Pedreira; Marina Cury Gallotini Magalhães; Camila Lopes Cardoso; Luís Antônio de Assis Taveira; Cláudio Froes de Freitas
Journal:  J Appl Oral Sci       Date:  2007-12       Impact factor: 2.698

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.